Latest news
First patient dosed in clinical study about stroke-related disability - Scientist LiveScientist Live · Fri, 07 Aug 2026 11:17:21 GMTFirst patient dosed with DISP-10 in Dispatch Bio’s cancer trial - YahooYahoo · Fri, 07 Aug 2026 09:47:43 GMTTheriva Biologics Doses First Patient in VIRAGE2 Trial of VCN-01 for Metastatic Pancreatic Cancer - The Clinical Trial VanguardThe Clinical Trial Vanguard · Fri, 07 Aug 2026 06:44:00 GMTTheriva Biologics (NYSE American: TOVX) starts VIRAGE2 Phase 2a trial in PDAC - Stock TitanStock Titan · Thu, 06 Aug 2026 12:11:14 GMTTheriva™ Biologics Announces First Patient Dosed in VIRAGE2 - GlobeNewswireGlobeNewswire · Thu, 06 Aug 2026 12:00:00 GMTTheriva’s Six-Patient Cancer Trial Is Designed to Test Repeat Virus Dosing - Stock TitanStock Titan · Thu, 06 Aug 2026 12:00:00 GMTSystImmune doses first patient in Phase III trial for ES-SCLC - Clinical Trials ArenaClinical Trials Arena · Thu, 06 Aug 2026 10:25:17 GMTMigraine Biotech Doses First Patient in Phase 2b EVO756 Trial - Streetwise ReportsStreetwise Reports · Thu, 06 Aug 2026 09:41:48 GMT